CoChat

Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model

Open access
Schreiber, Stefanie, Bueche, Celine Zoe, Garz, Cornelia, Braun, Holger · 2013 · Experimental & Translational Stroke Medicine

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Abstract

Cerebral small vessel disease (CSVD, cerebral microangiopathy) leads to dementia and stroke-like symptoms. Lacunes, white matter lesions (WML) and microbleeds are the main pathological correlates depicted in in-vivo imaging diagnostics. Early studies described segmental arterial wall disorganizations of small penetrating cerebral arteries as the most pronounced underlying histopathology of lacunes. Luminal narrowing caused by arteriolosclerosis was supposed to result in hypoperfusion with WML and infarcts.We have used the model of spontaneously hypertensive stroke-prone rats (SHRSP) for a longitudinal study to elucidate early histological changes in small cerebral vessels. We suggest that endothelial injuries lead to multiple sites with blood brain barrier (BBB) leakage which cause an ongoing damage of the vessel wall and finally resulting in vessel ruptures and microbleeds. These microbleeds together with reactive small vessel occlusions induce overt cystic infarcts of the surrounding parenchyma. Thus, multiple endothelial leakage sites seem to be the starting point of cerebral microangiopathy. The vascular system reacts with an activated coagulatory state to these early endothelial injuries and by this induces the formation of stases, accumulations of erythrocytes, which represent the earliest detectable histological peculiarity of small vessel disease in SHRSP.In this review we focus on the meaning of the BBB breakdown in CSVD and finally discuss possible consequences for clinicians.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/2040-7378-5-4

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Stases, BBB disturbances and microvascular dysfunction in SHRSP. Erythrocyte accumulations (stases) in a capillary (A, hippocampus) and arterioles (B - D, basal ganglia) associated with endothelial injury indicated by beginning diapedesis of erythrocytes (B &C, white arrows) and IgG-deposits within the wall of affected vessels (E &F; E, erythrocyte autofluorescence in magenta). Stases might be the consequence of erythrocyte accumulations (G &H, white arrows) within a mesh of thrombocytes (G) and threads of the von-Willebrand-factor (vWF; H) both activated by blood brain barrier breakdown as illustrated by wall adherence of the vWF in small vessels with IgG deposits (I). Note the disturbed vascular tone in small vessels with stases indicated by sausage-like wall dilatations, here shown in a striatal trifurcation of arterioles (D). E is taken from [25]. A – D Hematoxylin Eosin (HE) staining. STL - solanum tuberosum lectin used as endothelial marker, Laminin used as basement membrane marker.
Figure 1 Stases, BBB disturbances and microvascular dysfunction in SHRSP. Erythrocyte accumulations (stases) in a capillary (A, hippocampus) and arterioles (B - D, basal ganglia) associated with endothelial injury indicated by beginning diapedesis of erythrocytes (B &C, white arrows) and IgG-deposits within the wall of affected vessels (E &F; E, erythrocyte autofluorescence in magenta). Stases might be the consequence of erythrocyte accumulations (G &H, white arrows) within a mesh of thrombocytes (G) and threads of the von-Willebrand-factor (vWF; H) both activated by blood brain barrier breakdown as illustrated by wall adherence of the vWF in small vessels with IgG deposits (I). Note the disturbed vascular tone in small vessels with stases indicated by sausage-like wall dilatations, here shown in a striatal trifurcation of arterioles (D). E is taken from [25]. A – D Hematoxylin Eosin (HE) staining. STL - solanum tuberosum lectin used as endothelial marker, Laminin used as basement membrane marker.CC BY · PubMed Central
Figure 2 Degenerative small vessel wall changes, small bleeds and infarcts in SHRSP. Degenerative small vessel wall changes include arteriolosclerosis (A &B, hippocampus), lipohyalinosis (C, basal ganglia) and thickening of the extracellular matrix (D, hippocampus &E, basal ganglia) with associated enlarged perivascular spaces (A – C). Erythrocytes, leaking through injured small vessel walls, form perivascular bleeds (F &G, cortex). Reactive small vessel occlusions (white asterisks) surrounded by perivascular mini- and microbleeds (H &I, cortex) with consecutive infarcts consisting of spongy, cystic and hemorrhagic tissue (I) are the consequence and represent the final stage of cerebral small vessel disease in SHRSP. A &B – Congo red staining, C, F - I - HE staining, D &E – Movat staining.
Figure 2 Degenerative small vessel wall changes, small bleeds and infarcts in SHRSP. Degenerative small vessel wall changes include arteriolosclerosis (A &B, hippocampus), lipohyalinosis (C, basal ganglia) and thickening of the extracellular matrix (D, hippocampus &E, basal ganglia) with associated enlarged perivascular spaces (A – C). Erythrocytes, leaking through injured small vessel walls, form perivascular bleeds (F &G, cortex). Reactive small vessel occlusions (white asterisks) surrounded by perivascular mini- and microbleeds (H &I, cortex) with consecutive infarcts consisting of spongy, cystic and hemorrhagic tissue (I) are the consequence and represent the final stage of cerebral small vessel disease in SHRSP. A &B – Congo red staining, C, F - I - HE staining, D &E – Movat staining.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 146

Metadata

Authors
Schreiber, S., Bueche, C. Z., Garz, C., & Braun, H.
Affiliations
  • German Center for Neurodegenerative Diseases (DE)
  • Otto-von-Guericke-Universität Magdeburg (DE)
Corresponding author
Schreiber, Stefanie
Venue
Experimental & Translational Stroke Medicine
Published
2013-03-14
Volume
5
Issue
1
Pages
4-4
ISSN
2040-7378 (ISSN-L)
OpenAlex
W2106468847
Cited by
144
References
41
Citations by year
2026: 10 · 2025: 9 · 2024: 11 · 2023: 9 · 2022: 17 · 2021: 11 · 2020: 6 · 2019: 13 · 2018: 14 · 2017: 7 · 2016: 15 · 2015: 6 · 2014: 10 · 2013: 6
FWCI
7.83
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Experimental & Translational Stroke Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DZNE Pub (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords
cerebral small vessel disease, blood-brain barrier disruption, endothelial injury, microbleeds, lacunes, white matter lesions, cerebrovascular disease, stroke-prone spontaneously hypertensive rats, vessel wall damage, coagulation activation, cerebral microangiopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model. https://app.cochat.ai/papers/10.1186/2040-7378-5-4
The paper
Schreiber, S., Bueche, C. Z., Garz, C., & Braun, H. (2013). Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model. Experimental & Translational Stroke Medicine. https://doi.org/10.1186/2040-7378-5-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.